No Detail Found!

Association of Methylenetetrahydrofolate Reductase Gene 677c>t Polymorphism with Post-stroke Depression Risk and Antidepressant Treatment Response in Han Chinese.

Author(s)
Feng Mei Department of Psychology, Nanjing Brain Hospital Affiliated to Nanjing Medical University,
Yanfeng Wu Department of Neurology, the Second Affiliated Hospital of Nanjing Medical University, China
Guibing Ding Department of Neurology, the Second Affiliated Hospital of Nanjing Medical University, China
Fenghua Pan Department of Neurology, the Second Affiliated Hospital of Nanjing Medical University, China
Liang Chen Department of Neurology, the Second Affiliated Hospital of Nanjing Medical University, China
Jin Wu Department of Neurology, the Second Affiliated Hospital of Nanjing Medical University, China
Abstract
Objectives: To investigate the association of methylenetetrahydrofolate reductase gene 677C>T polymorphism with post-stroke depression risk and antidepressant treatment response in Han Chinese. Methods: This cross-sectional study was conducted at the Department of Neurology and Neurosurgery, the Second Affiliated Hospital of Nanjing Medical University and Nanjing Brain Hospital, China, between February 2010 and December 2014. It comprised patients who had experienced first-episode acute stroke. Psychological assessment was performed at day 7, 1 month, 3 months and 6 months after stroke. Post-stroke depression patients were characterised by clinical response to anti-depressive pharmacological treatment measured by intra-individual changes based on the 17-item Hamilton rating scale for depression scores. Results: Of the total 292 patients, 11(3.76%) were lost during 6-month follow-up. Our final analysis comprised 106(36.3%) post-stroke depression patients and 175(59.93%) post-stroke depression-free patients. The 677T allele and 677C/T genotype of methylenetetrahydrofolate reductase gene 677C>T polymorphism, which were overrepresented in depression patients and were respectively associated with 1.82-fold (p=0.001) and 3.65-fold (p0.05). Conclusions: Mutation of methylenetetrahydrofolate reductase gene 677C>T polymorphism was found to be significantly associated with the increased risk of post-stroke depression, but not with treatment response.
Publication Details
Page(s) 888-892
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 6, Year: 2018

Request the full text from PASTIC

Keywords
Polymorphism, Post-stroke depression, post-stroke depression, Methylenetetrahydrofolate reductase, Antidepressant treatment response
References
GotheF,EnacheD,WahlundLO,WinbladB,CrisbyM,LokkJ, 2012.Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment,Panminerva Med 54 161 -70
PaolucciS. Epidemiology, 2008.and treatment of post-stroke depression,Neuropsychiatr Dis Treat 4 145 -54
LiJ,OakleyLD,BrownRL,LiY,Ye M Luo Y. Early, 2016.symptom measurement of Post-Stroke Depression (PSD),J Affect Disord 197 215 -22
SwartzRH,BayleyM,LanctotKL,MurrayBJ,CayleyML,LienK, 2016.Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screening,Int J Stroke 11 509 -18
TrimmerEE, 2013.Methylenetetrahydrofolate reductase: biochemical characterization and medical significance,Curr Pharm Des 19 2574 -2593
BottiglieriT,LaundyM,CrellinR,TooneBK,CarneyMW,ReynoldsEH, 2000.Homocysteine, folate, methylation, and monoamine metabolism in depression,J Neurol Neurosurg Psychiatry 69 228 -32
TolmunenT,HintikkaJ,VoutilainenS,RuusunenA,AlfthanG,NyyssonenK, 2004.Association between depressive symptoms and serum concentrations of homocysteine in men: a population study,Am J Clin Nutr 80 1574 -8
NaumovskiN,VeyseyM,NgX,BoydL,DufficyL,BladesB, 2010.The folic acid endophenotype and depression in an elderly population,J Nutr Health Aging 14 829 -33
AlmeidaOP,McCaulK,HankeyGJ,NormanP,Jamrozik K Flicker L., 2008.Homocysteine and depression in later life,Arch Gen Psychiatry 65 1286 -94
DelavaranH,JönssonAC,LövkvistH,IwarssonS,ElmståhlS,NorrvingB, 2017.Cognitive function in stroke survivors: A 10- year follow-up study,Acta Neurol Scand 136 187 -94
1988.The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration,WHO MONICA Project Principal Investigators. J Clin Epidemiol 41 105 -14
ZhouZ,LuT,XuG,YueX,ZhuW,MaM, 2011.Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism,Clin Chem Lab Med 49 185 -9
RobinsonRG, 2003.Poststroke depression: prevalence, diagnosis, treatment, and disease progression,Biol Psychiatry 54 376 -87
SerrettiA,OlgiatiP,BajoE,Bigelli M De Ronchi D, 2011.A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders,World J Biol Psychiatry 12 501 -15
JiangW,XuJ,LuXJ,SunY., 2016.Association between MTHFR C677T polymorphism and depression: a meta-analysis in the Chinese population,Psychol Health Med 21 675 -85
LewisSJ,LawlorDA,Davey SmithG,ArayaR,TimpsonN,DayIN, 2006.The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis,Mol Psychiatry 11 352 -60
KellyCB,McDonnellAP,JohnstonTG,MulhollandC,CooperSJ,McMasterD, 2004.The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland,J Psychopharmacol 18 567 -71
2012.Analysis of genetic polymorphisms of brain-derived neurotrophic factor and methylenetetrahydrofolate reductase in depressed patients in a Slovak (Caucasian) population,Gen Physiol Biophys 31 415 -22
2012.Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults,J Nutr 142 1554 -60
TriantafyllouN,EvangelopoulosME,KimiskidisVK,KararizouE,BoufidouF,FountoulakisKN, 2008.Increased plasma homocysteine levels in patients with multiple sclerosis and depression,Ann Gen Psychiatry 7 17 -
MischoulonD,Lamon-FavaS,SelhubJ,KatzJ,PapakostasGI,IosifescuDV, 2012.Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment,CNS Spectr 17 76 -86
SunXY,ZhangZJ,ShiYY,XuZ,PuMJ,GengLY, 2013.Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response],Zhonghua Yi Xue Yi Chuan Xue Za Zhi 30 26 -30
LizerMH,BogdanRL, 2011.Comparison of the frequency of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in depressed versus nondepressed patients,J Psychiatr Pract 17 404 -9
Mech AW Farah, 2016.A. Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism: a randomized, doubleblind, placebo-controlled study,J Clin Psychiatry 77 668 -71
EszlariN,KovacsD,PetschnerP,PapD,GondaX,ElliottR, 2016.Distinct effects of folate pathway genes MTHFR and MTHFD1L on ruminative response style: a potential risk mechanism for depression,Transl Psychiatry 6 e745 -
0

Citations

0

Downloads

111

Views